The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adherence to ASCO Language of Respect (LoR) guidelines in urothelial carcinoma (UC) abstracts at the 2023 ASCO Annual Meeting.
 
Daniela V. Castro
No Relationships to Disclose
 
Benjamin D. Mercier
No Relationships to Disclose
 
Miguel Zugman
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Regina Barragan-Carrillo
No Relationships to Disclose
 
Megan Hoikei Wong
No Relationships to Disclose
 
Ethan Chan
No Relationships to Disclose
 
Amber Faridi
No Relationships to Disclose
 
Jaya Goud
No Relationships to Disclose
 
Trishita Paul
No Relationships to Disclose
 
Akasha Dukkipati
No Relationships to Disclose
 
Jalen Patel
No Relationships to Disclose
 
Teebro Paul
No Relationships to Disclose
 
Hedyeh Ebrahimi
No Relationships to Disclose
 
Neal Shiv Chawla
No Relationships to Disclose
 
Alex Chehrazi-Raffle
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Tempus
Research Funding - Exelixis
 
Tatiana Michelle Prowell
No Relationships to Disclose
 
Narjust Florez
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Janssen; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Pfizer; Regeneron
Other Relationship - Medscape; MJH Life Sciences
 
Nazli Dizman
Stock and Other Ownership Interests - Biofarma Ilac (I)
Consulting or Advisory Role - Vivreon Biosciences
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen